Sepsis and AMR: Diagnostic Innovation and Targeted Therapy – Free Webinar on November 20, 2025
Antimicrobial resistance (AMR) and sepsis remain two of the most urgent and interconnected global health threats in 2025. In honor of World AMR Awareness Week, the GSA is partnering with Biotest, Menarini, and bioMérieux to offer three free webinars on AMR and sepsis.
We are starting next Thursday, November 20, with the World Sepsis Congress Satellite Session on “Sepsis and AMR: Diagnostic Innovation and Targeted Therapy”, to explore how innovation and collaboration can change the trajectory of both.
In this 90-minute session, leading experts from the WHO, academia, and industry will discuss the latest advances in diagnostics, targeted therapy, and antimicrobial stewardship—as well as the vital role of patient and family advocacy in improving outcomes.
Date and Time
🗓️ Date: Thursday, November 20, 2025
🕛 Time: 12:00 – 13:30 CET/Berlin
Register Now
Speakers include:
Prof. Konrad Reinhart – Founding President, Global Sepsis Alliance, Germany
Dr. Benedikt Huttner – World Health Organization, Switzerland (to be confirmed)
Dr. Kristoffer Strålin – Associate Professor, Karolinska Institutet, Sweden
Mariah McKimbrough – Sepsis Survivor and Advocate, Sepsis Stiftung, Germany
Prof. Evangelos Giamarallos-Bourboulis – Chair, European Sepsis Alliance
This session will be moderated by Duncan Brown, Chair of the GSA Global Sepsis Survivor and Family Committee.
We look forward to welcoming you to the livestream next Thursday!